Abstract
Background Medications in which the risk of adverse events exceeds the expectations of clinical benefits are called potentially inappropriate medications (PIMs). To identify the use of PIMs in elderly patients, the most commonly used tool are the Beers criteria, developed for the population of the United States. Recently, a consensus panel of Argentine experts developed the first Latin American tool, called the IFAsPIAM List. Objective The present study aimed to identify PIM prescriptions in elderly outpatients, to estimate the prevalence of PIMs, and to evaluate their possible relation with polypharmacy and gender and age of the patients. Also, we aimed to compare the results obtained by using the Beers criteria and the IFAsPIAM List. Setting Ten community pharmacies of Rosario, Santa Fe, Argentina. Methods A cross-sectional observational study was conducted between February and September 2015. Data were acquired from 56,952 prescriptions prescribed to 2231 patients aged 65 years old or older. To detect the use of PIMs, we used two tools: the Beers criteria and the IFAsPIAM List. Main outcome measure The prevalence of PIM use according to the Beers criteria and the IFAsPIAM List. Results The monthly average of medications dispensed per patient was 4.35 ± 2.18 and 42.27% of the patients presented major polypharmacy. The prevalence of PIMs was 72.75% according to the Beers criteria and 71.13% according to the IFAsPIAM List (Kappa coefficient k = 0.72), and was significantly higher in patients with major polypharmacy, older than 75 years old, and females. The most frequent PIMs prescribed were anxiolytics, analgesics and antipsychotics. Conclusions The IFAsPIAM List is an effective tool to evaluate the prescription of PIMs in the elderly. The results showed a high prevalence of PIMs with a multicausal origin and directly associated with polypharmacy. As clarified by the authors of the IFAsPIAM List, the criteria specified in the list do not substitute the clinical evaluation of each patient.
Similar content being viewed by others
References
Pandraud-Riguet I, Bonnet-Zamponi D, Bourcier E, Buyse M, Laribe-Caget S, Frémont P, et al. Monitoring of potentially inappropriate prescriptions in older inpatients: a French multicenter study. J Am Geriatr Soc. 2017;65(12):2713–9.
IDELAS-UCES. La población argentina aumentó su edad promedio respecto de la media del mundo. In: Boletín Mensual IDELAS. http://la5pata.com/2017/02/09/idelas-uces-la-poblacion-argentina-aumento-su-edad-promedio/. Accessed 1 Dec 2018.
World Health Organization. A glossary of terms for community health care and services for older persons. WHO Centre for Health Development; 2004.
Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53(1):7–11.
Chiapella LC, Montemarani Menna J, Mamprin ME. Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation. Int J Clin Pharm. 2018. https://doi.org/10.1007/s11096-018-0663-3.
Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31(1):42–51.
Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63(2):177–86.
Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.
Steinman MA, Beizer JL, DuBeau CE, Laird RD, Lundebjerg NE, Mulhausen P. How to use the American Geriatrics Society 2015 Beers Criteria—a guide for patients, clinicians, health systems, and payors. J Am Geriatr Soc. 2015;63(12):e1–7.
Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arzteblatt Int. 2010;107(31–32):543–51.
O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Renom-Guiteras A, Meyer G, Thürmann PA. The EU (7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–75.
Oliveira M, Amorim W, Oliveira C, Coqueiro H, Gusmão L, Passos L. Consenso brasileiro de medicamentos potencialmente inapropriados para idosos. Geriatr Gerontol Aging. 2016;10(4):168–81.
Marzi MM, Pires MS, Quaglia NB. Ingredientes Farmaceuticos Activos Potencialmente Inapropiados en Adultos Mayores: Lista IFAsPIAM: Panel de Consenso Argentino. Value Health Reg Issues. 2018;17:38–55.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2016. 19 ed. Oslo, Norway: 2015.
Chiapella LC, Montemarani Menna J, Mamprin ME. Potentially inappropriate medications in elderly ambulatory patients: a comparative study between a primary health care center and a community pharmacy. Value Health Reg Issues. 2018;17:119–25.
Anmat. Vademecum Nacional de Medicamentos. http://anmatvademecum.servicios.pami.org.ar/. Accessed 1 Dec 2018.
American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.
Holmes HM, Luo R, Kuo YF, Baillargeon J, Goodwin JS. Association of potentially inappropriate medication use with patient and prescriber characteristics in Medicare Part D. Pharmacoepidemiol Drug Saf. 2013;22(7):728–34.
Lopes LM, Figueiredo TP, Costa SC, Reis AM. Use of potentially inappropriate medications by the elderly at home. Ciencia saude coletiva. 2016;21(11):3429–38.
Cano JP, García AA, Cánovas JJG, Ruiz JFS, Rausell VJR, Soto MT. Prescripción potencialmente inadecuada en mayores de 65 años según los criterios de Beers originales y su versión adaptada. Atención Primaria. 2018;50(2):106–13.
Fajreldines A, Insua J, Schnitzler E. Prevalencia de prescripcion potencialmente inapropiada de medicamentos en adultos mayores. Revista de calidad asistencial: organo de la Sociedad Espanola de Calidad Asistencial. 2016;31(5):279–84.
Chang CM, Liu PYY, Yang YHK, Yang YC, Wu CF, Lu FH. Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy. 2005;25(6):831–8.
Bertoldo P, Beltramo A, Rimoldi E, Bertoldo J, Vidaurre M, Valenciaga M, et al. Patrones de prescripción de benzodiacepinas, antidepresivos e hipnóticos en diferentes ciudades de Argentina. Rev AAFH. 2018;5(1):4–15.
Díaz-Gutiérrez MJ, Martinez-Cengotitabengoa M, de Adana ES, Cano AI, Martínez-Cengotitabengoa MT, Besga A, et al. Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas. 2017;101:17–22.
Thaler HW, Sterke C, Van Der Cammen TJ. Association of proton pump inhibitor use with recurrent falls and risk of fractures in older women: a study of medication use in older fallers. J Nutr Health Aging. 2016;20(1):77–81.
World Health Organization. WHO’s pain ladder. 2011. http://www.who.int/cancer/palliative/painladder/en. Accessed 2 Dec 2018.
Campbell S, Cantrill J. Consensus methods in prescribing research. J Clin Pharm Ther. 2001;26(1):5–14.
Weyer G, Babej-Dölle R, Hadler D, Hofmann S, Herrmann W. A controlled study of 2 doses of idebenone in the treatment of Alzheimer’s disease. Neuropsychobiology. 1997;36(2):73–82.
Mariotti C, Solari A, Torta D, Marano L, Fiorentini C, Di Donato S. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology. 2003;60(10):1676–9.
Gómez V, Armesto J, Calvo M, Candás M, Fidalgo S, Rigeira A. Utilidad terapéutica de los medicamentos financiados por el Sistema Nacional de Salud. Madrid: INSALUD; 2001.
Makari J, Cameron K, Battistella M. Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review. Can J Hosp Pharm. 2014;67(6):441.
Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, et al. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria. Eur J Clin Pharmacol. 2016;72(5):583–91.
Chang CB, Yang SY, Lai HY, Wu RS, Liu HC, Hsu HY, et al. Application of three different sets of explicit criteria for assessing inappropriate prescribing in older patients: a nationwide prevalence study of ambulatory care visits in Taiwan. BMJ Open. 2015;5(11):e008214.
Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123–32.
Cojutti P, Arnoldo L, Cattani G, Brusaferro S, Pea F. Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs? Pharmacoepidemiol Drug Saf. 2016;25(9):1070–8.
Chui MA, Stone JA, Holden RJ. Improving over-the-counter medication safety for older adults: a study protocol for a demonstration and dissemination study. Res Soc Adm Pharm. 2017;13(5):930–7.
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.
Funding
This study was supported by Universidad Nacional de Rosario (No. 445/2015) and a grant from Secretaría de Estado de Ciencia, Tecnología e Innovación-SECTEI-(No. 2010-174-14), Santa Fe, Argentina.
Conflicts of interest
The authors report no conflict of interest in the conduction of this study or the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chiapella, L.C., Montemarani Menna, J., Marzi, M. et al. Prevalence of potentially inappropriate medications in older adults in Argentina using Beers criteria and the IFAsPIAM List. Int J Clin Pharm 41, 913–919 (2019). https://doi.org/10.1007/s11096-019-00858-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-019-00858-8